Claude Libert Selected Research

Neuroinflammatory Diseases

1/2018	A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation.
1/2015	Decreased TNF Levels and Improved Retinal Ganglion Cell Survival in MMP-2 Null Mice Suggest a Role for MMP-2 as TNF Sheddase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claude Libert Research Topics

Disease

47	Inflammation (Inflammations) 01/2022 - 04/2004
28	Sepsis (Septicemia) 01/2022 - 01/2007
25	Neoplasms (Cancer) 01/2019 - 09/2002
11	Infections 01/2021 - 08/2005
10	Shock 10/2020 - 07/2002
6	Endotoxemia 01/2020 - 03/2014
6	Septic Shock (Toxic Shock Syndrome) 01/2020 - 04/2009
5	Glucocorticoid Receptor Deficiency 01/2021 - 08/2010
5	Crohn Disease (Crohn's Disease) 10/2020 - 10/2011
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 12/2005
5	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 11/2007
5	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 08/2010
4	Hypoxia (Hypoxemia) 01/2022 - 01/2020
4	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2020 - 08/2008
4	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2016 - 10/2011
4	Hepatitis 01/2016 - 12/2005
4	Disease Progression 09/2011 - 12/2007
4	Fibrosis (Cirrhosis) 08/2010 - 11/2007
3	Immune System Diseases (Immune Disorders) 08/2022 - 10/2011
3	Starvation 01/2022 - 01/2020
3	Colitis 12/2021 - 12/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2015
3	Melanoma (Melanoma, Malignant) 07/2013 - 09/2007
3	Liver Neoplasms (Liver Cancer) 09/2010 - 01/2009
3	Liver Cirrhosis (Hepatic Cirrhosis) 08/2010 - 11/2007
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2015
2	Peritonitis 01/2019 - 03/2014
2	Cognitive Dysfunction 01/2019 - 01/2018
2	Obesity 01/2018 - 09/2010
2	Multiple Sclerosis 01/2018 - 01/2015
2	Neuroinflammatory Diseases 01/2018 - 01/2015
2	Encephalitis (Encephalitis, Rasmussen) 01/2018 - 07/2012
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2017 - 07/2008
2	Asthma (Bronchial Asthma) 01/2017 - 07/2004
2	Carcinogenesis 10/2015 - 11/2011
2	Pathologic Processes 01/2015 - 04/2009
2	Necrosis 12/2011 - 11/2005
2	Reperfusion Injury 09/2011 - 10/2004
2	Dementia (Dementias) 10/2010 - 08/2010
2	Chronic Hepatitis B 02/2010 - 08/2005
2	Acute Liver Failure (Fulminant Hepatic Failure) 04/2008 - 08/2005
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2022
1	Glioma (Gliomas) 10/2022

Drug/Important Bio-Agent (IBA)

28	GlucocorticoidsIBA 08/2022 - 12/2005
22	CytokinesIBA 10/2020 - 07/2002
18	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022 - 07/2011
13	Polysaccharides (Glycans)IBA 01/2018 - 11/2007
13	Matrix Metalloproteinases (MMPs)IBA 09/2015 - 04/2004
12	Pharmaceutical PreparationsIBA 11/2021 - 04/2004
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 07/2002
9	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2007
9	Proteins (Proteins, Gene)FDA Link 12/2021 - 08/2005
7	Type I Tumor Necrosis Factor ReceptorsIBA 01/2019 - 08/2014
5	LipopolysaccharidesIBA 01/2022 - 02/2012
5	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019 - 12/2011
5	Blood Proteins (Serum Proteins)IBA 01/2018 - 02/2009
5	ChemokinesIBA 09/2015 - 02/2005
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2005
4	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2011
4	ZincIBA 10/2020 - 08/2007
4	Therapeutic UsesIBA 01/2020 - 08/2009
4	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 10/2011
4	Interleukin-17 (Interleukin 17)IBA 06/2015 - 08/2008
3	SteroidsIBA 01/2021 - 08/2010
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 09/2009
3	Messenger RNA (mRNA)IBA 01/2019 - 12/2011
3	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019 - 09/2009
3	Biological ProductsIBA 01/2019 - 02/2005
3	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2018 - 12/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2018 - 09/2010
3	Imiquimod (Aldara)FDA LinkGeneric 12/2016 - 06/2015
3	Glycoproteins (Glycoprotein)IBA 02/2016 - 10/2004
3	Matrix Metalloproteinase InhibitorsIBA 12/2014 - 04/2009
3	Interferon Type IIBA 03/2014 - 01/2007
3	Peptides (Polypeptides)IBA 08/2010 - 09/2002
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2022 - 01/2021
2	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 01/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 01/2019
2	LipidsIBA 01/2020 - 01/2016
2	EndotoxinsIBA 01/2019 - 11/2016
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2015 - 02/2007
2	Dextran SulfateIBA 10/2015 - 12/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2015 - 09/2010
2	AntigensIBA 12/2014 - 12/2011
2	Poly I-CIBA 07/2013 - 04/2008
2	LigandsIBA 02/2012 - 02/2006
2	DNA (Deoxyribonucleic Acid)IBA 08/2010 - 04/2008
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2009 - 12/2003
2	NF-kappa B (NF-kB)IBA 09/2009 - 08/2005
2	Peptide Hydrolases (Proteases)FDA Link 04/2009 - 08/2006
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 12/2008 - 08/2007
2	GalactosamineIBA 11/2005 - 08/2005
1	Bacterial Proteins (Bacterial Protein)IBA 11/2021

Therapy/Procedure

23	Therapeutics 01/2020 - 07/2002
10	Punctures 01/2019 - 04/2011
10	Ligation 01/2019 - 04/2011
3	Resuscitation 10/2018 - 08/2018
3	Critical Care (Surgical Intensive Care) 10/2018 - 08/2018
3	Immunotherapy 12/2014 - 12/2011